Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:FWBI

First Wave BioPharma (FWBI) Stock Price, News & Analysis

First Wave BioPharma logo

About First Wave BioPharma Stock (NASDAQ:FWBI)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$2.60
$4.63
52-Week Range
N/A
Volume
56,500 shs
Average Volume
212,944 shs
Market Capitalization
$7.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive FWBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for First Wave BioPharma and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

FWBI Stock News Headlines

ENTO Entero Therapeutics, Inc.
How to trade Cryptos using Elliott Wave
Capital Gains Tax Strategies for Seniors
Capital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holding investments longer to using tax-advantaged accounts and strategic loss offsetting, there are ways to reduce your exposure. SmartAsset outlines three capital gains tax strategies for seniors and offers a free tool to connect you with vetted fiduciary financial advisors who can help tailor these tactics to your situation.tc pixel
See More Headlines

FWBI Stock Analysis - Frequently Asked Questions

First Wave BioPharma, Inc. (NASDAQ:FWBI) posted its quarterly earnings results on Sunday, November, 14th. The company reported ($13,734.00) EPS for the quarter, missing analysts' consensus estimates of ($3,318.00) by $10,416.00.

Shares of First Wave BioPharma reverse split before market open on Monday, December 18th 2023.The 1-20 reverse split was announced on Monday, December 18th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, December 18th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that First Wave BioPharma investors own include Tesla (TSLA), HIVE Digital Technologies (HIVE), Shopify (SHOP), BIOLASE (BIOL), Meta Platforms (META) and PayPal (PYPL).

Company Calendar

Last Earnings
11/14/2021
Today
8/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:FWBI
CIK
1604191
Fax
N/A
Employees
9
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$15.80 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-102.83%
Return on Assets
-22.74%

Debt

Debt-to-Equity Ratio
0.40
Current Ratio
1.21
Quick Ratio
1.58

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.54 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
2,480,000
Free Float
2,463,000
Market Cap
$7.34 million
Optionable
Not Optionable
Beta
1.28
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:FWBI) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners